TC
CHRS icon

TownSquare Capital’s Coherus Oncology CHRS Stock Holding History

TownSquare Capital’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35,280
Closed -$563K – 721
2021
Q4 		$563K Buy
35,280
+7,994
+29% +$140K 0.01% 455
2021
Q3 		$438K Buy
27,286
+12,553
+85% +$184K 0.01% 477
2021
Q2 		$201K Buy
+14,733
New +$209K 0.01% 588

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TownSquare Capital's CHRS Position: Q1 2022 in Review

TownSquare Capital sold out of Coherus Oncology (CHRS) in Q1 2022, closing a stake of 35,280 shares — an estimated $563K sold.

TownSquare Capital first reported a position in CHRS in Q2 2021 and held it in 3 quarters. The position peaked at $563K in Q4 2021. 183 funds tracked by Wall St. Rank hold CHRS as of Q1 2022.

  • TownSquare Capital reported no remaining Coherus Oncology position as of Q1 2022 after selling out during the quarter.
  • TownSquare Capital sold 35,280 Coherus Oncology shares in Q1 2022, an estimated $563K.
  • TownSquare Capital first reported a position in Coherus Oncology in Q2 2021 and held it in 3 quarters.
  • TownSquare Capital's Coherus Oncology position peaked at $563K in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2022.

Based on TownSquare Capital's 13F filing for Q1 2022, filed 28 Apr 2022.